Healthcare Industry News: BladderScan
News Release - May 18, 2007
Verathon(R) Inc. Launches Portable BladderScan(R) BVI 9400 Bladder Volume Instrument with NeuralHarmonics(TM) Ultrasound Technology at AUABOTHELL, Wash., May 18 (HSMN NewsFeed) -- Verathon® (formerly Diagnostic Ultrasound) is pleased to announce the introduction of the portable BladderScan® BVI 9400 bladder volume instrument with patent pending NeuralHarmonics(TM) Technology. This latest addition to the BladderScan® brand, the gold standard in bladder volume measurement, will make its debut at the American Urological Association (AUA) Annual Meeting in Anaheim, California on May 19th. (Verathon Booth #540)
Designed for Urologists, Primary Care Physicians, Acute and Extended Care facilities, to help prevent unnecessary catheterization, diagnose urinary retention and to help evaluate common urological conditions, this new ultrasound instrument offers sharpened accuracy and accelerated speed in bladder volume measurement. Additional innovations include improved aiming via Probe and Console, and a unique method of wireless data transfer for patient record keeping.
The BladderScan® BVI 9400 incorporates a new technology in the science of ultrasound; NeuralHarmonics(TM) (patent pending). Found only in BladderScan® instruments, NeuralHarmonics(TM) Technology, (from "neural network"* harmonics) improves both speed and accuracy in bladder volume measurement. NeuralHarmonics(TM) Technology reduces error and minimizes uncertainty in essential measurements of bladder function by creating previously unattainable differentiation of the bladder, urine and hypo-echogenic regions such as the uterus. This technology, also based on the principle of "neural networks" applies a multi-spectral analysis to a robust data set -- giving clinicians definitive, intelligent diagnostic capabilities in bladder measurement.
"The new BVI 9400 is a perfect combination of our advanced technology, NeuralHarmonics(TM), and all the attributes our users tell us they love about the BladderScan® such as ease of use, reliability, etc.," stated Gerald McMorrow, CEO, Founder and Chairman of the Board of Verathon, Inc. "We worked diligently on this new technology over several years. It's been our goal to improve healthcare by providing well-designed instruments that make a difference."
The BVI 9400 is quick and easy to use. Unlike other ultrasound machines, no sonographer is required. When the scan button is pressed, the instrument measures ultrasonic reflections on multiple planes inside the body and produces a three dimensional image. Based on this image, the BVI 9400 calculates and displays the bladder volume. To facilitate training, both a "user" video and a "NeuralHarmonics(TM) Technology" video are provided on the Console.
The BVI 9400 also offers users improvements in aiming, on both the ergonomic Probe and the Console. A new, larger color display with brightness control tilts for easy viewing, and voice annotation for patient record keeping is also offered. Healthcare providers have the option of using the readout provided by the Console, the printout provided by the onboard printer or the EMR related report provided via HIPAA compliant ScanPoint® online technology. A unique Wireless Hub transfers exams to ScanPoint® for viewing, saving and printing. The Hub also serves as a Battery Charger with two battery bays. ScanPoint® subscribers may calibrate their instrument on line quickly and easily; the process takes only 15 minutes.
For more information, please visit http://www.verathon.com.
About Verathon Inc.
Verathon®, formerly Diagnostic Ultrasound Corp., designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan® instrument is the standard of care for bladder volume measurement. The brand is found in over 60 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon® entered Anesthesiology, Critical Care and Emergency markets with the GlideScope® Video Laryngoscope (GVL®) brand. Verathon® is headquartered in Bothell, Washington and has approximately 270 employees worldwide. For more information, please visit http://www.verathon.com.
Media Contact: Jane Mueller, VP of Marketing, Verathon Medical Inc., 425.867-1348, Ext. 6060. Also: Carol Klimas, OffMadisonAve, 480.505-4500. Alternate Contacts: Joyce Chee, Executive Assistant - Marketing, 425.867.1348 Ext. 6064; Jessica McNerney, Executive Assistant to Gerald McMorrow, Verathon Inc., 425.867.1348, Ext. 1448.
Copyright © 2007, Verathon Inc. BladderScan®, GlideScope®, GVL®, Verathon®, and Verathon Medical®are either registered trademarks or trademarks of Verathon Inc. in the United States and/or other countries. All rights reserved.
* Neural Network: A computer architecture in which a number of processors are interconnected in a manner suggestive of the connections between neurons in a human brain and which is able to learn.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.